Page last updated: 2024-08-23

etoposide and bay 1000394

etoposide has been researched along with bay 1000394 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lienau, P; Lücking, U; Mumberg, D; Schatz, C; Siemeister, G; Steinke, W; Wengner, AM; Ziegelbauer, K1
Albert, I; Barlesi, F; Bidoli, P; Cadranel, J; Chung, J; Drews, U; Fritsch, A; Govindan, R; Horn, L; Juhász, E; Kowalski, D; Novello, S; Reck, M; Robinet, G; Wagner, A1
Li, Z; Lu, S1

Trials

1 trial(s) available for etoposide and bay 1000394

ArticleYear
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019, Volume: 14, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Progression-Free Survival; Pyrimidines; Small Cell Lung Carcinoma; Sulfoxides

2019

Other Studies

2 other study(ies) available for etoposide and bay 1000394

ArticleYear
BAY 1000394, a novel cyclin-dependent kinase inhibitor, with potent antitumor activity in mono- and in combination treatment upon oral application.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:10

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cisplatin; Cyclin-Dependent Kinases; Etoposide; Female; Humans; Mice; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Rats; Retinoblastoma Protein; Sulfoxides; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Pyrimidines; Small Cell Lung Carcinoma; Sulfoxides

2019